Provided by Tiger Trade Technology Pte. Ltd.

Amphastar Pharmaceuticals

21.60
-0.0800-0.37%
Post-market: 21.600.00000.00%19:30 EDT
Volume:376.56K
Turnover:8.16M
Market Cap:918.82M
PE:12.80
High:22.20
Open:21.64
Low:21.44
Close:21.68
52wk High:31.26
52wk Low:16.65
Shares:42.54M
Float Shares:30.52M
Volume Ratio:0.94
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.69
EPS(LYR):2.03
ROE:10.30%
ROA:5.11%
PB:1.20
PE(LYR):10.64

Loading ...

Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 16, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
May 09, 2023

Major Issues Report

8-K - Current report
May 09, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Major Issues Report

8-K - Current report
Apr 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 13, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 10, 2023

Major Issues Report

8-K - Current report
Mar 01, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 01, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2023

Major Issues Report

8-K - Current report